ELLIOTT KAGAN
Medical Practice at Royal Oak Ct, Rockville, MD
License number
DC MD12685
Issued Date
Nov 3, 1981
Expiration Date
Apr 30, 1997
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
4 Royal Oak Ct, Rockville, MD 20854
Personal information
See more information about ELLIOTT KAGAN at radaris.comName
Address
Phone
4 Royal Oak Ct, Potomac, MD 20854
112 Kendrick Pl, Gaithersburg, MD 20878
4 Royal Oak Ct, Potomac, MD 20854
Professional information
See more information about ELLIOTT KAGAN at trustoria.com
Sirna Silencing Of Filovirus Gene Expression
Sirna Silencing Of Filovirus Gene Expression
US Patent:
2007013, Jun 14, 2007
Filed:
Oct 20, 2006
Appl. No.:
11/584341
Inventors:
Ian MacLachlan - Vancouver, CA
Vandana Sood - Vancouver, CA
Thomas Geisbert - Harpers Ferry WV, US
Lisa Hensley - Frederick MD, US
Elliott Kagan - Potomac MD, US
Vandana Sood - Vancouver, CA
Thomas Geisbert - Harpers Ferry WV, US
Lisa Hensley - Frederick MD, US
Elliott Kagan - Potomac MD, US
Assignee:
Protiva Biotherapeutics, Inc. - Burnaby
International Classification:
A61K 48/00, C07H 21/02, A61K 9/127
US Classification:
514044000, 536023100, 424450000, 977907000
Abstract:
The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.
Sirna Silencing Of Filovirus Gene Expression
Sirna Silencing Of Filovirus Gene Expression
US Patent:
2011017, Jul 21, 2011
Filed:
Sep 9, 2010
Appl. No.:
12/878946
Inventors:
Ian MacLachlan - Mission, CA
Vandana Sood - Vancouver, CA
Thomas W. Geisbert - Albany TX, US
Lisa E. Hensley - Frederick MD, US
Elliott Kagan - Potomac MD, US
Vandana Sood - Vancouver, CA
Thomas W. Geisbert - Albany TX, US
Lisa E. Hensley - Frederick MD, US
Elliott Kagan - Potomac MD, US
Assignee:
Protiva Biotherapeutics, Inc. - Burnaby BC
International Classification:
A61K 31/713, C07H 21/02, A61K 9/00, A61P 31/14, B82Y 5/00
US Classification:
424400, 536 245, 514 44 A, 977773, 977915
Abstract:
The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.